302,000 Shares in PureTech Health plc (NASDAQ:PRTC) Acquired by Birch Hill Investment Advisors LLC

Birch Hill Investment Advisors LLC purchased a new stake in PureTech Health plc (NASDAQ:PRTC) during the fourth quarter, Holdings Channel.com reports. The firm purchased 302,000 shares of the company’s stock, valued at approximately $5,575,000.

PureTech Health Trading Down 1.4 %

Shares of PureTech Health stock opened at $18.88 on Friday. The company has a 50-day simple moving average of $19.47 and a two-hundred day simple moving average of $20.62. PureTech Health plc has a one year low of $17.00 and a one year high of $34.00.

PureTech Health Company Profile

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.